CIK 0001412486
- Non-accelerated filer
- Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352528215
- Phone
- +1 786-459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-09 | Martin James Joseph Co-CEO and CFO | Grant or award · Stock Options (Right to Buy) | +49,229 | 49,229 | ||
| 2025-10-28 | Martin James Joseph Co-CEO and CFO | Grant or award | +3,598 | $1.39 | $5K | 44,167 |
| 2025-10-28 | Martin James Joseph Co-CEO and CFO | Grant or award · Warrants | +7,196 | $1.39 | $10K | 7,196 |
| 2024-10-09 | Martin James Joseph Co-CEO and CFO | Grant or award | +40,000 | 40,569 | ||
| 2023-07-18 | Martin James Joseph Co-CEO and CFO | Grant or award · Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2022-07-25 | Martin James Joseph Co- Interim CEO and CFO | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2021-07-16 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2020-06-22 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2018-09-21 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 9 trades